Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

HemoCleanse licenses bioartificial liver technology from Monsanto

Jan. 14, 1997

OXIS files IND for BXT-51072

Jan. 13, 1997

VIMRxyn enters clinical testing in HCV-infected patients

Jan. 9, 1997

ISIS-2302 update

Jan. 9, 1997

Oxis International completes phase I testing of IBD treatment

Jan. 8, 1997

Anti-HCV agents revealed by Japanese and Chinese investigators

Jan. 8, 1997

Prokinetic agents from Tokyo Tanabe

Jan. 8, 1997

Shin Nippon discloses antiulcer agents

Jan. 7, 1997

Lansoprazole equieffective to omeprazole in Dutch trial

Jan. 2, 1997

Novel human serine protease inhibitor for pancreatitis claimed by Incyte

Jan. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...